Q1 2017 Holdings
Filed 2017-05-12 | 139 holdings | $253.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $132.6M | 484,974 | 52.3% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $44.4M | 505,845 | 17.5% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $12.5M | 243,995 | 4.9% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $11.4M | 127,100 | 4.5% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $10.1M | 231,200 | 4.0% |
| CytomX Therapeutics, Inc.(CTMX) | Common | 23284F105 | $9.2M | 530,092 | 3.6% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $8.1M | 639,370 | 3.2% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $8.1M | 1,466,368 | 3.2% |
| Cellectis S.A.(CLLS) | Sponsored ADR | 15117K103 | $7.4M | 310,250 | 2.9% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $3.2M | 87,531 | 1.3% |
| Coherus BioSciences, Inc.(CHRS) | Common | 19249H103 | $1.9M | 90,000 | 0.8% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $1.8M | 203,935 | 0.7% |
| Allscripts Healthcare Solutions, Inc.(MDRX) | Common | 01988P108 | $600.0K | 47,300 | 0.2% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $171.8K | 2,530,131 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $170.0K | 1,366,605 | 0.1% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $113.0K | 1,033,503 | 0.0% |
| Amgen Inc.(AMGN) | Common | 031162100 | $112.4K | 684,824 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $96.5K | 795,905 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $92.7K | 693,275 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $89.0K | 714,362 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $76.1K | 1,198,349 | 0.0% |
| Allergan plc | Shares | G0177J108 | $74.2K | 310,610 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $72.7K | 187,666 | 0.0% |
| Mylan N.V. | Shares | N59465109 | $60.5K | 1,550,412 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $51.2K | 1,152,520 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $50.7K | 297,360 | 0.0% |
| UnitedHealth Group Inc.(UNH) | Common | 91324P102 | $50.3K | 306,852 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $49.4K | 613,030 | 0.0% |
| Jazz Pharmaceuticals plc(JAZZ) | Shares | G50871105 | $48.1K | 331,411 | 0.0% |
| Eli Lilly & Company(LLY) | Common | 532457108 | $41.5K | 493,100 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $40.3K | 231,413 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $39.2K | 1,146,689 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $35.0K | 228,020 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | Sponsored ADR | 881624209 | $32.6K | 1,015,758 | 0.0% |
| CVS Health Corporation(CVS) | Common | 126650100 | $32.3K | 411,891 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $31.7K | 153,800 | 0.0% |
| AmerisourceBergen Corporation(COR) | Common | 03073E105 | $29.3K | 330,687 | 0.0% |
| iShares Nasdaq Biotechnology ETF(IBB) | Nasdaq Biotech ETF | 464287556 | $22.9K | 77,970 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $20.5K | 132,352 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $19.3K | 446,074 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $18.5K | 248,800 | 0.0% |
| Molina Healthcare, Inc.(MOH) | Common | 60855R100 | $18.4K | 402,541 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $16.8K | 113,100 | 0.0% |
| Spdr S&P Biotech ETF(XBI) | S&P Biotech ETF | 78464A870 | $15.7K | 226,460 | 0.0% |
| Sabra Health Care REIT, Inc.(SBRA) | Common | 78573L106 | $15.4K | 550,990 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $15.1K | 511,600 | 0.0% |
| GlaxoSmithKline plc | Sponsored ADR | 37733W105 | $15.1K | 359,000 | 0.0% |
| Omega Healthcare Investors, Inc.(OHI) | Common | 681936100 | $15.1K | 458,616 | 0.0% |
| Paratek Pharmaceuticals, Inc. | Common | 699374302 | $14.7K | 762,581 | 0.0% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $14.4K | 463,800 | 0.0% |